BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8409464)

  • 1. Affinity cleavage of cell surface antibodies using the avidin-biotin system.
    Alon R; Bayer EA; Wilchek M
    J Immunol Methods; 1993 Sep; 165(1):127-34. PubMed ID: 8409464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avidin- or streptavidin-biotin as a highly sensitive method to stain total protein on membranes.
    Santora KE; Nelson SA; Lewis KA; LaRochelle WJ
    Mol Biotechnol; 2000 Jun; 15(2):161-5. PubMed ID: 10949830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization.
    Casalini P; Luison E; Ménard S; Colnaghi MI; Paganelli G; Canevari S
    J Nucl Med; 1997 Sep; 38(9):1378-81. PubMed ID: 9293791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoaffinity isolation of membrane antigens with biotinylated monoclonal antibodies and immobilized streptavidin matrices.
    Updyke TV; Nicolson GL
    J Immunol Methods; 1984 Oct; 73(1):83-95. PubMed ID: 6386987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody fragments in tumor pretargeting. Evaluation of biotinylated Fab' colocalization with recombinant streptavidin and avidin.
    Wilbur DS; Hamlin DK; Vessella RL; Stray JE; Buhler KR; Stayton PS; Klumb LA; Pathare PM; Weerawarna SA
    Bioconjug Chem; 1996; 7(6):689-702. PubMed ID: 8950488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptavidin-biotin immunotoxins: a new approach to purging bone marrow.
    Meyer BF; Stoner ML; Raphael CL; Davis RE; Herrmann RP
    Exp Hematol; 1991 Aug; 19(7):710-3. PubMed ID: 1893957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of toxoplasma membrane antigens transferred from SDS-polyacrylamide gel to nitrocellulose with monoclonal antibody and avidin-biotin, peroxidase anti-peroxidase and immunoperoxidase methods.
    Ogata K; Arakawa M; Kasahara T; Shioiri-Nakano K; Hiraoka K
    J Immunol Methods; 1983 Dec; 65(1-2):75-82. PubMed ID: 6361144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity cleavage and targeted catalysis of proteins using the avidin-biotin system.
    Bayer EA; Grootjans JJ; Alon R; Wilchek M
    Biochemistry; 1990 Dec; 29(51):11274-9. PubMed ID: 2271711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved targeting of radiolabeled streptavidin in tumors pretargeted with biotinylated monoclonal antibodies through an avidin chase.
    Yao Z; Zhang M; Kobayashi H; Sakahara H; Nakada H; Yamashina I; Konishi J
    J Nucl Med; 1995 May; 36(5):837-41. PubMed ID: 7738661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avidin-biotin system in enzyme immunoassays.
    Ternynck T; Avrameas S
    Methods Enzymol; 1990; 184():469-81. PubMed ID: 2201882
    [No Abstract]   [Full Text] [Related]  

  • 11. A monoclonal antibody to avidin dissociates quaternary structure and curtails biotin binding to avidin and streptavidin.
    Subramanian N; Subramanian S; Karande AA; Adiga PR
    Arch Biochem Biophys; 1997 Aug; 344(2):281-8. PubMed ID: 9264540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific selection of lymphocyte subpopulations by avidin-biotin immune rosetting.
    Lucas PJ; Gress RE
    J Immunol Methods; 1987 May; 99(2):185-90. PubMed ID: 3108407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive selection of viable cell populations using avidin-biotin immunoadsorption.
    Berenson RJ; Bensinger WI; Kalamasz D
    J Immunol Methods; 1986 Jul; 91(1):11-9. PubMed ID: 3088123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of Daudi lymphoblasts from human bone marrow using avidin-biotin immunoadsorption.
    Berenson RJ; Bensinger WI; Kalamasz D; Martin P
    Blood; 1986 Feb; 67(2):509-15. PubMed ID: 3510682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immobilized nitro-avidin and nitro-streptavidin as reusable affinity matrices for application in avidin-biotin technology.
    Morag E; Bayer EA; Wilchek M
    Anal Biochem; 1996 Dec; 243(2):257-63. PubMed ID: 8954558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug targeting to the brain using avidin-biotin technology in the mouse; (blood-brain barrier, monoclonal antibody, transferrin receptor, Alzheimer's disease).
    Jeong Lee H; Pardridge WM
    J Drug Target; 2000; 8(6):413-24. PubMed ID: 11328667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoradiometric assay of carcinoembryonic antigen with use of avidin-biotin labeling.
    Peters J; Schmidt-Gayk H; Peters B; Armbruster FP; Quentmeier A; Mathias D
    Clin Chem; 1989 Apr; 35(4):573-6. PubMed ID: 2649275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor.
    Yoshikawa T; Pardridge WM
    J Pharmacol Exp Ther; 1992 Nov; 263(2):897-903. PubMed ID: 1432704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of two immunoperoxidase staining methods based on the avidin-biotin interaction.
    Giorno R
    Diagn Immunol; 1984; 2(3):161-6. PubMed ID: 6388981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tumor cell growth by aggregation of a tumor-associated glycolipid antigen: a close functional association between gangliotriaosylceramide and transferrin receptor in mouse lymphoma L-5178Y.
    Okada Y; Matsuura H; Hakomori S
    Cancer Res; 1985 Jun; 45(6):2793-801. PubMed ID: 2985252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.